Interpretation of negative epidemiological evidence for carcinogenicity. Statistical considerations
Day, N.E.
Iarc Scientific Publications 65: 13-27
1985
ISSN/ISBN: 0300-5038 PMID: 4086079 Document Number: 248047
Document emailed within 1 workday
Related Documents
MacMahon, B. 1994: The epidemiological evidence on the carcinogenicity of beryllium in humans Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 36(1): 15-24; Discussion 25-6Swenberg, J.A. 2004: Toxicological considerations in the application and interpretation of DNA adducts in epidemiological studies Iarc Scientific Publications 157: 237-246
Maksimovich, D.M.; Parfenov, I.D. 1990: Statistical methods in the study of carcinogenicity in animal experiments Voprosy Onkologii 36(3): 276-285
Sunderman, F.W.; McCully, K.S.; Rinehimer, L.A. 1981: Negative test for transplacental carcinogenicity of nickel subsulfide in Fischer rats Research Communications in Chemical Pathology and Pharmacology 31(3): 545-554
Landrigan, P.J. 1993: Critical assessment of epidemiological studies on the carcinogenicity of 1,3-butadiene and styrene Iarc Scientific Publications 127: 375-388
Habs, M.; Eisenbrand, G.; Habs, H.; Schmähl, D. 1982: No evidence of carcinogenicity of N-nitrosocimetidine in rats Hepato-Gastroenterology 29(6): 265-266
Longstaff, E.; Walker, A.I.; Jäckh, R. 1984: Nickel oxide: potential carcinogenicity--a review and further evidence Iarc Scientific Publications 53: 235-243
Chaturvedi, S.; Chaturvedi, S. 2001: Carcinogenicity of asbestos: convincing evidence, conflicting interests National Medical Journal of India 14(1): 43-46
Vogel, J.P.; Oxman, A.D.; Glenton, C.; Rosenbaum, S.; Lewin, S.; Gülmezoglu, A.Metin.; Souza, Jão.Paulo. 2013: Policymakers' and other stakeholders' perceptions of key considerations for health system decisions and the presentation of evidence to inform those considerations: an international survey Health Research Policy and Systems 11: 19
Branzi, A.; Rapezzi, C. 1988: Beta-blockade therapy in heart failure. Rational bases of the interpretation of clinical data and clinical evidence in search of rational interpretation Giornale Italiano di Cardiologia 18(10): 843-846
López-Jiménez, F.; Paniagua, D.; Lamas, G.A. 1998: Interpretation of negative clinical trials Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 50(5): 435-440
Lee, Y.J.; Wesley, R.A. 1981: Statistical contributions to phase Ii trials in cancer: interpretation, analysis and design Seminars in Oncology 8(4): 403-416
André, F.E.; van Strik, R. 1974: Statistical concepts in the interpretation of sterility tests on influenza virus vaccine Developments in Biological Standardization 23: 157-164
Ostermann, Rüdiger.; Wilhelm, A.F.X.; Wolf-Ostermann, K. 2004: Presentation of statistical data in nursing 6--Line diagrams: the risk of false interpretation Pflege Zeitschrift 57(6): 408-410
Casula, D.; Nissardi, G.P.; Sanna-Randaccio, F.; Carta, P.; Anni, M.S. 1975: Considerations on the physiological interpretation of the exercise test with increasing load Bollettino della Societa Italiana di Biologia Sperimentale 51(21): 1480-1485
Borrelli, R.; Cole, T.J.; Di Biase, G.; Contaldo, F. 1989: Some statistical considerations on dietary assessment methods European Journal of Clinical Nutrition 43(7): 453-463
Luparello, D.; Bruschi, S.; Verna, G.; Bogetti, P.; Datta, G.; Fraccalvieri, M.; Luparello, V. 1998: Cranioplasty with polymethylmethacrylate. the clinico-statistical considerations Minerva Chirurgica 53(6): 575-579
Watanabe, N. 2006: Interpretation and the use of evidence in psychiatry Seishin Shinkeigaku Zasshi 108(9): 982-990
Arrotta, U.; Alpinelli, P. 1984: Extrauterine tubal pregnancy. Clinico-statistical considerations Minerva Ginecologica 36(7-8): 399-402
Suárez, E.; Sariol, C.A.; Burguete, A.; Mclachlan, G. 2007: A tutorial in genetic epidemiology and some considerations in statistical modeling Puerto Rico Health Sciences Journal 26(4): 401-421